Skip to content
Checked.be
Complete company report
Generated 12-08-2026
Active BE 0805.076.640Private limited company

RED Medical

Peperdam(VRA) 6 ·9120 Beveren-Kruibeke-Zwijndrecht, Belgium· 2 yrs active
Sector: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies (70200)
Conclusion Checked

The computed 12-month bankruptcy probability of RED Medical is 0.3% (very low). The 2025 annual accounts show equity of €310k and a net result of €201k. Equity is growing by ~138.3% per year across the filed fiscal years. Its solvency ranks better than 85% of 4723 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.
Key figures
Equity €310k
Net result €201k
Better than sector 85%
Active 2 yrs
Snowflake analysis 5 of 5 axes measured · computed by Checked
Health100Profitability100Solvency100Growth78Stability82
92 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 100
Profitability 100
Solvency 100
Growth 78
Stability 82
Bankruptcy probability (12 mo) Checked model v1 · free
0.3% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector −Young company +Annual accounts: healthy financial profile −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 2 signals
Young company
Founded in 2023, under 3 years, statistically higher risk.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags 0 events
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Health barometer FY 2025 · computed
100 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview3 NBB filings
Annual accounts filed on 17-02-2026 with the NBB · fiscal year 2025 · micro
€0€100k€200k€300kOperating result 2023: €9k€9kNet result 2023: €6k€6kOperating result 2024: €132k€132kNet result 2024: €100k€100kOperating result 2025: €269k€269kNet result 2025: €201k€201k202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~138.3%/year over 3 fiscal years, indicative, assuming unchanged policy.
€0€200k€400k€600k€800k2026: €460k (€435k - €485k)2027: €610k (€586k - €635k)2028: €761k (€736k - €786k)2023: €9k2024: €109k2025: €310k202320242025202620272028
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 70, Head offices & management consulting · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 85.3% 55.5%
better than 85% of 4723 sector peers
Net result €201k €38k
better than 95% of 4722 sector peers
Equity €310k €64k
better than 90% of 4723 sector peers
Gross operating margin €272k €61k
better than 95% of 4715 sector peers
Total assets €363k €146k
better than 81% of 4723 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
EBITDA
€270k
+102.0% 23-25
Net profit
€201k
+100.9% 23-25
Cash flow
€202k
+98.3% 23-25
Total assets
€363k
+152.9% 23-25
Equity
€310k
+184.7% 23-25
Working capital
€307k
+188.0% 23-25
Income taxes
€69k
+116.8% 23-25
Debt
€53k
+53.4% 23-25
Debt ≤ 1y
€53k
+53.4% 23-25
Current ratio
6.78
+66.2% 23-25
Quick ratio
6.78
+66.2% 23-25
Solvency
85.3%
+12.5% 23-25
Debt / equity
0.17
-46.1% 23-25
ROE
64.9%
-29.4% 23-25
ROA
55.4%
-20.6% 23-25
Interest coverage
3546.47
+272.0% 23-25
Figures by fiscal year
Fiscal year2025
Depositmicro
Revenue-
EBITDA€270k
Net profit€201k
Cash flow€202k
Staff costs-
Income taxes€69k
Dividends-
Total assets€363k
Equity€310k
Debt€53k
of which ≤ 1y€53k
of which > 1y-
Working capital€307k
Employees (FTE)-
Ratios (computed)
2025
Current ratio6.78
Quick ratio6.78
Working capital ratio84.7%
Solvency85.3%
Debt / equity0.17
Long-term debt ratio-
Interest coverage3546.47
Gross margin-
Net margin-
ROA55.4%
ROE64.9%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€363k
Fixed assets 21/28€2k
Tangible fixed assets 22/27€2k
Current assets 29/58€361k
Amounts receivable within one year 40/41€22k
Investments 50/53€331k
Cash & bank 54/58€5k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€363k
Equity 10/15€310k
Contributions / capital 10/11€3k
Reserves 13€307k
Amounts payable 17/49€53k
Amounts payable within one year 42/48€53k
Trade debts payable within one year 44€3k
Income statement
Gross operating margin 9900€272k
Operating result 9901€269k
Financial income 75€994
Financial charges 65€76
Result before taxes 9903€270k
Income taxes 67/77€69k
Net result for the period 9904€201k
Result to be appropriated 9905€201k
You're seeing the latest fiscal year only. Unlock 2 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.
Legal Structure
NACE primary Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies(70200)
Legal form Private limited company(610)
Incorporation24-08-2023
StatusActive
Postal code9120
Establishment units 1 location
RED Medical
Peperdam(VRA) 6, 9120 Beveren-Kruibeke-ZwijndrechtVervaardiging van andere chemische producten, neg
since 20232.348.506.194
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
46028B0700/00L000 Flanders 505 m² 1 · 107 m² 8.7 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 4 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026
17-02-2026
NBB filing Annual accounts filed
fiscal year 2025 · micro
2025
03-06-2025
NBB filing Annual accounts filed
fiscal year 2024 · micro
22-04-2025
State Gazette act Minor change
Agm rules change · Joost EEMAN
2024
24-07-2024
NBB filing Annual accounts filed
fiscal year 2023 · micro
Belgisch Staatsblad, acts 1 acts
All acts · 1 updated 1 year ago
2025
22-04-2025 Publication in the Belgian Official Gazette, Minor change Minor change·Joost EEMAN
Summary: Agm rules changeNotary: Joost EEMAN · Gent
Technical details 
{
  "notary": {
    "name": "Joost EEMAN",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Gent",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-04-22",
    "filing_date": "2025-04-17",
    "act_kind_objet": "DOEL"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "date": "2025-04-15",
    "unanimous": true
  },
  "agm_change": {
    "new_schedule": null,
    "old_schedule": null,
    "effective_from_year": null,
    "rule_changes_summary": "Wijziging van artikel 3 van de statuten om het voorwerp van de vennootschap te wijzigen en uit te breiden."
  },
  "detected_kind": "agm_rules_change",
  "other_address": null,
  "mandate_renewal": null,
  "subject_company": {
    "kbo": "0805.076.640",
    "name_full": "RED Medical",
    "legal_form": "BV"
  },
  "accounts_deposit": null,
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null
  },
  "co_filed_documents": [],
  "fiscal_year_change": null,
  "liquidation_closure": null,
  "officer_designation": null,
  "special_procuration": null,
  "is_volet_a_only_stub": false,
  "vakbekwaamheid_change": null,
  "should_reroute_to_category": null,
  "single_shareholder_declaration": null
}
Credit advice verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Company registry (CBE) Crossroads Bank
Activities
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies70200Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering70220Vervaardiging van andere chemische producten, n.e.g.20590Vervaardiging van andere chemische producten, neg20590Vervaardiging van overige farmaceutische producten21209Vervaardiging van overige farmaceutische producten21209Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden32500Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden32500Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460Overige dienstverlenende activiteiten op het gebied van informatie63920Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.63990
Primary activity highlighted.
Names & trade names
Legal nameNL RED Medical
Registered office
Peperdam(VRA) 6
9120 Beveren-Kruibeke-Zwijndrecht, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Comparable size · 15,322 of 81,966 companies in this sector with filed accounts
BUILD CONSULTANCE & MANAGEMENT BE 0785.270.032 · Manhay
D.ConsulT BE 0761.408.230 · Gingelom
LENIMACO BE 0802.666.783 · Liège
EKOSYS BE 0786.783.925 · Villers-la-Ville
ARANDRA BE 1005.191.303 · Charleroi
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative